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Abstract 44 
Background: Risk stratification is challenging in conditions, such as chest pain, 45 
shortness of breath and syncope, which can be the manifestation of many possible 46 
underlying diseases. In these cases, decision tools are unlikely to accurately identify all the 47 
different adverse events related to the possible etiologies. Attribute matching is a prediction 48 
method that matches an individual patient to a group of previously observed patients with 49 
identical characteristics and known outcome. We used syncope as a paradigm of clinical 50 
conditions presenting with aspecific symptoms to test the attribute matching method for the 51 
prediction of the personalized risk of adverse events. Methods: We selected the 8 predictor 52 
variables common to the individual-patient dataset of 5 prospective emergency department 53 
studies enrolling 3388 syncope patients. We calculated all possible combinations and the 54 
number of patients in each combination. We compared the predictive accuracy of attribute 55 
matching and logistic regression. We then classified ten random patients according to 56 
clinical judgment and attribute matching. Results: Attribute matching provided 253 of the 57 
384 possible combinations in the dataset. Twelve (4.7%), 35 (13.8%), 50 (19.8%) and 160 58 
(63.2%) combinations had a match size ≥50, ≥30, ≥20 and <10 patients, respectively. The 59 
AUC for the attribute matching and the multivariate model were 0.59 and 0.74, respectively. 60 
Conclusions: Attribute matching is a promising tool for personalized and flexible risk 61 
prediction. Large databases will need to be used in future studies to test and apply the 62 
method in different conditions. 63 
Keywords: syncope; attribute matching; risk; prediction; personalized; emergency. 64 
 65 
Introduction 66 
Clinical decision tools (CDT) combine different predictors (from patients¶ history, 67 
clinical examination and tests results) to assess the probability of a diagnosis, prognosis, or 68 
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response to treatment of an individual patient [1]. The statistical techniques used in this 69 
process are usually based on multivariate models such as logistic regression [2]. Other 70 
approaches include recursive partitioning analysis and artificial neural networks [3–5]. As 71 
they are based on models, CDTs are able to predict the risk of any hypothetical patient, even 72 
those with a combination of risk factors different from all the patients of the derivation 73 
cohort. Therefore, we do not know how the CDT will perform in subjects with specific 74 
clinical presentations or needs. Indeed, they lack the ability to provide personalized 75 
estimates as required in the era of precision medicine. For example, patients with 76 
uncommon diseases are likely not to be correctly risk stratified by CDTs. In addition, the 77 
risk estimates of composite outcomes that are usually provided by CDTs cannot always be 78 
applied to all patients, as the definition of ³acceptable risk´ depends on the patient at risk. 79 
Hence the need to assess a personalized risk rather than providing a simple binary answer 80 
[6]. 81 
Moreover, risk stratification is challenging in conditions (as chest pain, shortness of 82 
breath and syncope) presenting with aspecific symptoms that can be the manifestation of 83 
many possible underlying diseases. In these cases, decision tools are unlikely to accurately 84 
identify all the different adverse events related to the possible etiologies. In syncope, which 85 
is a paradigm of the above conditions, the traditionally derived risk stratification tools have 86 
failed in predicting adverse events [7–12]. Here, an individualized risk assessment would 87 
allow an estimate of not only the probability of a composite endpoint, but rather a detailed 88 
risk profile that provides the individual risk of each specific outcome (e.g. arrhythmia or 89 
pulmonary embolism).  90 
Attribute matching (AM) is a prediction approach that differs considerably from the 91 
regression models and has shown promising results in ruling out acute coronary syndrome 92 
and pulmonary embolism in patients with chest pain [13–15]. Instead of considering each 93 
clinical characteristic as an individual predictor and deriving a risk estimate based on the 94 
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sum of their regression coefficients, each individual patient is matched to a group of patients 95 
with the same combination of the relevant clinical characteristics (or attributes) from a large 96 
reference database. Therefore, each patient is matched to a group of patients with identical 97 
risk profile and known outcomes. This approach results in a proportion (i.e. the number 98 
patients who had the outcome of interest on the number of previously studied matched 99 
patients) that provides the probability (with confidence interval) of the single adverse event. 100 
This process resembles the definition of pre-test probability by an expert clinician, which, 101 
having seen many patients who had similar clinical characteristics as the patient under 102 
consideration, could provide an estimate of the probability of something bad happening. In 103 
this case, the computer does so with less variability and without the clinician having to be 104 
experienced nor an expert. The aim of this study was to explore the use of AM to predict the 105 
personalized risk of adverse events and to compare it to multivariate logistic regression to 106 
analyze the possible similarities, differences, strengths and weaknesses of the two methods 107 
using syncope in the Emergency Department (ED) as an example. 108 
 109 
Materials and Methods 110 
To apply AM in a large database, we used an individual-patient dataset from a previous 111 
international collaboration that involved 3388 patients prospectively included in 5 studies 112 
enrolling syncope patients in the ED from 2000 to 2014 [8,16–20]. The dataset was 113 
analyzed to detect demographic and clinical variables among those considered to be 114 
relevant for syncope risk stratification as have shown to be related to adverse events 115 
[16,17,19,21]. Each single dataset was re-analyzed to create homogeneously defined 116 
variables for abnormal electrocardiogram (ECG) and 7-10 day serious outcomes [7,12,22]. 117 
We finally identified the variables that were available in all 5 datasets. 118 
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The AM estimates of the probability of serious adverse is based upon computer 119 
assisted, database-derived system. The clinician puts in a predefined set of clinical attributes 120 
for a subject for whom the probability of a serious outcome is unknown. A computer 121 
program queries a large patient database, and returns only the patients who share the 122 
identical attribute profile as the patient under consideration. The proportion of these 123 
attribute-matched subjects who had a clinical outcome of interest is the probability of 124 
adverse events. 125 
According to the ³Standardized reporting guidelines for emergency department 126 
syncope risk-stratification research´ serious outcomes included any of the following [22]: 127 
1) all-cause and syncope-related death, 2) ventricular fibrillation, 3) sustained and 128 
symptomatic non-sustained ventricular tachycardia, 4) sinus arrest with cardiac pause > 3 s, 129 
5) sick sinus syndrome with alternating bradycardia and tachycardia, 6) second-degree type 130 
2 or third-degree AV block, 7) permanent pacemaker (PM) or implantable cardioverter 131 
defibrillator (ICD) malfunction with cardiac pauses, 8) aortic stenosis with valve area ≤ 1 132 
cm2, 9) hypertrophic cardiomyopathy with outÀow tract obstruction, 10) left atrial myxoma 133 
or thrombus with outÀow tract obstruction, 11) myocardial infarction, 12) pulmonary 134 
embolism, 13) aortic dissection, 14) occult hemorrhage or anemia requiring transfusion, 15) 135 
syncope or fall resulting in major traumatic injury (requiring admission or 136 
procedural/surgical intervention), 16) PM or ICD implantation, 17) cardiopulmonary 137 
resuscitation, 18) syncope recurrence with hospital admission, and 19) cerebrovascular 138 
events.  139 
To explore the potential application of AM in this context, we calculated 1) all the 140 
unique combinations of the selected variables (or attributes); 2) the number of combinations 141 
verified in at least one patient in the database; 3) the number of combinations with a match 142 
size ≥50, ≥ 30, ≥20 and <10 patients. 143 
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The potential predictors of short-term severe outcomes were first individually 144 
evaluated and then analyzed by multivariate logistic regression analysis with a stepwise 145 
selection strategy. In case of one predictor was missing in one patient, it was considered as 146 
absent.  147 
The overall diagnostic performance of both multivariate logistic regression and AM was 148 
assessed with Receiver Operating Characteristics (ROC) curves and their area under the curve 149 
(AUC).To exemplify how the AM would work in the real world, we considered 10 random 150 
patients who presented with syncope, as defined according to the main international 151 
guidelines and consensus papers [11,12], to the ED of Fondazione IRCCS Ca¶ Granda, 152 
Ospedale Maggiore Policlinico, Milano from September 2015 to February 2017 [23]. For 153 
each patient we recorded the presence or absence of any of the above attributes and 154 
calculated the risk of adverse events according to the AM approach. For this purpose we 155 
paired the patient of interest to the patients with an identical combination of attributes in the 156 
database and calculated the probability of adverse events as the percentage of the matched 157 
previously studied patients who had the outcome of interest [13]. A 95% confidence interval 158 
(CI) was constructed using the binomial distribution. As part of a larger study on syncope 159 
ED risk stratification, we asked the ED physician to assess the patient¶s risk of short-term 160 
adverse events (low, intermediate or high) according to his/her clinical judgement.  161 
The data for this study were collected and analyzed anonymously. The 10 patients in 162 
Table 4 had given written informed to have their data collected and the Internal Review 163 
Board of L. Sacco Hospital (approval number 608/2015) had approved their use for this 164 
study purpose. IRB approval was obtained by the single primary study authors. 165 
Analyses were performed using the SAS (release 9.4) statistical software. 166 
 167 
Results 168 
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The main characteristics of the 3388 patients included in the individual-patient 169 
database are reported in Table 1. We identified 8 common predictors: sex, age (considered 170 
as a 3-level categorical variable: < 45 year, ≥ 45 and < 65 years, ≥ 65 years), trauma 171 
following syncope, presence of abnormal ECG, history of cerebrovascular disease, history 172 
of cardiac disease, history of syncope and absence of prodrome.  173 
Table 1. Characteristics of the included patients. 174 
Variables EGSYS [18,24] 
SFSR 
[19] 
STePS 
[16] 
ROSE 
[17] 
Sun 
2007 
[20] 
Total 
Total number of 
patients 465 684 695 1067 477 3388 
Age, median (IQR) 70  (45-81) 
70  
(42-81
) 
64  
(41-78) 
69  
(48-81) 
58  
(35-79) 
67  
(43-80) 
N of admitted 
patients (%) 178 (38) 
364 
(53) 265 (38) 538 (50) 
286 
(60) 
1631 
(48) 
N of men (%) 253 (54) 281 (41) 306 (44) 480 (45) 
210 
(44) 
1530 
(45) 
N of patients with 
history of syncope 
(%) 
195 (42) 124 (18) 389 (56) 176 (16) 
160/45
7 (34) 
1044/2
931 
(36) 
N of patients 
without prodrome 
(%) 
122 (26) 260 (38) 195 (28) 410 (38) 
141 
(30) 
1128 
(33) 
N of patients with 
trauma following 
syncope (%) 
133 (29) 45 (7) 162 (23) 316 (30) n.a. 656/2911 (23) 
N of patients with 
abnormal ECG (%) 178 (38) 
222 
(32) 202 (29) 665 (62) 
170 
(36) 
1437 
(42) 
N of patients with a 
history of 
cardiovascular 
disease (%) 
153 (33) 139 (20) 178 (26) 284 (27) 
150 
(31) 
904 
(27) 
N of patients with a 
history of 
cerebrovascular 
disease (%) 
166 (36) 115 (17) 227 (33) n.a. 
169 
(35) 
677/23
21 (29) 
N of patients with 
serious outcomes at 
10 days (%)* 
93 (20) 81 (12) 44 (6) 49 (5) 62 (13) 329 (10) 
N of deaths 6 6 7 6 1 26 (1) 
N of arrhythmias 31 30  20 32  
N of 
cardiopulmonary 
resuscitations 
  5 2   
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N of myocardial 
infarctions 6 33   1  
N of structural 
cardiopulmonary 
diseases 
9 10  14 6  
N of PM insertions 
or malfunctions 43  25 11 2  
N of ICD insertions 
or malfunctions 5  2    
N of haemorrhages  24  7 8  
IQR: interquartile range; ECG: electrocardiogram; PM: pacemaker; ICD: Implantable 175 
Cardioverter Defibrillator; n.a.: not available. *Some patients had more than one outcome. 176 
The AM method provided 253 of the 384 possible combinations. No patient in the 177 
database matched the remaining 131 combinations of predictors. Only 12 of the 253 (4.7%) 178 
combinations had a match size ≥50 patients, 35 (13.8%) had a match size ≥30 patients, 50 179 
(19.8%) had a match size ≥20 patients, and most (160, 63.2%) had a match size <10 180 
patients. 181 
At univariate analysis, the risk factors significantly associated with severe short-term 182 
outcomes were age, male gender, syncope during exertion, abnormal ECG, history of 183 
cardiovascular disease, history of cerebrovascular disease, absence of prodrome, and 184 
history of arterial hypertension (Table 2). 185 
Table 2. Risk factors for severe short-term outcomes within 10 days (univariate 186 
analysis) 187 
 Severe Outcomes 
 Yes (%) (n=329) 
No (%) 
(n=3059) p-value* 
Male gender, n (%) 196 (60) 1334 (44) <0.0001 
Age, n (%)   <0.0001 
< 45 years 24 (7) 869 (28)  
≥ 45 and < 65 years 56 (17) 658 (22)  
≥ 65 years 249 (76) 1532 (50)  
Syncope during exertion, n (%) 31 (9) 187 (6) 0.0211 
Trauma following syncope, n (%) 64 (19) 592 (19) 0.9651 
Abnormal ECG, n (%) 229 (70) 1208 (39) <0.0001 
Medical history, n (%)    
Cardiovascular disease 161 (49) 743 (24) <0.0001 
Cerebrovascular disease 132 (40) 545 (18) <0.0001 
Arterial hypertension 154 (47) 1104 (36) 0.0001 
Previous syncope 109 (33) 964 (31) 0.5491 
Absence of prodrome, n (%) 126 (38) 1002 (33) 0.0430 
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*Chi-square test; ECG: electrocardiogram 
At multivariate analysis, male gender, age between 45 and 65 years, age over 65 years, 188 
an abnormal ECG, and a past medical history of cerebrovascular disease were independent 189 
risk factors for the development of severe adverse outcomes in the short term (Table 3).  190 
Table 3. Risk factors for severe short-term outcomes within 10 days at logistic 191 
multivariate regression (stepwise selection) 192 
 Adjusted Odds 
Ratio 
95% 
Confidence 
Interval 
p-value* 
Male gender 1.6 1.3 – 2.0 0.0001 
Age   <0.0001 
< 45 years 1.0   
≥ 45 and < 65 years 2.3 1.4 – 3.8  
≥ 65 years 3.5 2.3 – 5.5  
Abnormal ECG 2.6 2.0 – 3.3 <0.0001 
Medical history of 
cerebrovascular disease 1.9 1.5 – 2.5 <0.0001 
*Chi-square test; ECG: electrocardiogram 
The AUC for the AM and the multivariate model were 0.59 and 0.74, respectively. 193 
The predicted probabilities for each of the 10 patients, together with the ED physician¶s 194 
perceived risk are reported in Table 4. To note, none of these patients had an adverse event 195 
at 7-30 days of follow-up according to standardized criteria [22]. The detailed case 196 
description of the 10 patients is reported in S1 Table. 197 
Table 4. Predicted probabilities according to attribute matching and clinical 198 
judgement in the 10 example patients. 199 
Case n 
Attribute matching 
ED physician patients at risk* 10-day SAE, % (95% CI) 
1 15 20 (7-45) High risk 
2 70 4 (1-12) Intermediate risk 
3 42 5 (1-16) Intermediate risk 
4 12 0 (0-24) Intermediate risk 
5 84 4 (1-10) Intermediate risk 
6 34 6 (2-19) Low risk 
7 42 5 (1-16) High risk 
8 6 16 (3-56) High risk 
9 6 0 (0-39) High risk 
10 3 33 (6-79) High risk 
ED: Emergency Department; SAE: serious adverse events; *: number of patients with the 200 
same combination of risk factors; CI: Confidence Interval. 201 
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 202 
Discussion 203 
In this paper, to assess the potential value of AM and to compare it to multivariate 204 
logistic regression we used syncope as a paradigm of those conditions, such as chest pain 205 
and shortness of breath, in which the creation of accurate CDTs is particularly challenging. 206 
If the condition under consideration is the manifestation of many possible underlying 207 
diseases, CDTs are unlikely to accurately identify all the different adverse events related to 208 
the possible etiologies [25]. In syncope, CDTs are usually designed to identify multiple 209 
diagnoses (i.e. pulmonary embolism, aortic dissection, high grade atrioventricular block) 210 
and adverse events that might be related to a high number of conditions (i.e. bleeding 211 
requiring transfusion, trauma, pacemaker implant). To increase complexity, the reference 212 
standard for diagnosis is sometimes missing. 213 
This study explores a method to estimate the probability of serious adverse events 214 
based on AM. This approach allows the clinician to determine the probability of a serious 215 
outcome of a patient based on the presence of predefined risk predictors (or attributes). This 216 
patient is matched to all patients with the same combination of attributes included in a large 217 
reference database. The proportion of these attribute-matched patients who had the outcome 218 
of interest represents the estimate, with its 95% confidence interval, of the probability that 219 
such outcome might occur in the patient under consideration [15]. This process resembles 220 
the definition of pre-test probability by an expert clinician, which, having seen many 221 
patients who had similar clinical characteristics as the patient under consideration, could 222 
provide an estimate of the probability of something bad happening. In this case the 223 
computer does so with less variability and without the clinician having to be experienced 224 
nor an expert. 225 
The inclusion of a large number of attributes would result in very specific and detailed 226 
clinical risk profiles at a cost of requiring a very large reference database. In the present 227 
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work, we used an eight-attribute profile and a 3388-patient database. Among the 384 228 
possible combinations, only 12 had a match size ≥50 patients and most had a match size <10 229 
patients. Therefore, our data do not offer a clinically useful prediction tool at this stage and 230 
the AUC shows that logistic regression is superior if derived from the dataset we used, but 231 
this method seems promising, as it has some advantages as compared to model-derived 232 
clinical decision tools. Indeed, the successful use of a model to predict the probability of a 233 
serious outcome requires that the results are reproduced in an external validation so that 234 
both the external validity and robustness of the model are verified. Moreover, models 235 
require that the predictors are assigned a weight that allow to estimate the risk of adverse 236 
events in every patient, also in those that had no matching subject in the derivation database 237 
(for example for patients that have a rare condition). Attribute matching differs from scoring 238 
systems derived from logistic regression, which use predictor variables expressed by an 239 
individual patient under consideration to guide that patient into a prede¿ned category that 240 
predicts a probability. This outcome probability is estimated from knowledge (i.e., the 241 
magnitude of importance of predictor variables) manifested by the patients that were used to 242 
construct the model. On the other hand, attribute matching works in reverse fashion. Instead 243 
of placing the patient under consideration into a category, the computer program ¿nds the 244 
patients from a reference database who µµlook like¶¶ the patient insofar as they are identical 245 
on the binary predictor variables. Therefore, the risk of patients with an uncommon 246 
combination of predictors, might not be able at all to find a match in the derivation dataset. 247 
However, being aware that the patient¶s estimated probability might be based on very 248 
limited evidence, will allow both the clinician and the patient to take a decision conscious 249 
that it might be based on uncertainty, rather than deciding on the false confidence provided 250 
by models.  251 
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Several thousands of subjects need to be enrolled for acceptable AM risk prediction. If this 252 
was the case, only administrative databases could be used to use AM for risk prediction. In 253 
the era of big data and with the increase in the availability and accuracy of population-based 254 
databases, this might not be a barrier to the use of AM for risk prediction in several 255 
conditions [26].  256 
AM has several advantages: 1) The possibility to have as output not only the probability 257 
of a composite serious outcome, but a detailed patient specific risk profile based on the 258 
probability of different outcomes allowing for a more personalized decision making. Also, 259 
the possibility to make the risk profile explicit and more personalized could allow for more 260 
meaningful shared decision making with the patient; 2) as there is no need for model fitting, 261 
patients could be always added to the dataset thus increasing the probability estimate 262 
precision; 3) the flexibility of AM would allow to consider different predictors in different 263 
patients, thus allowing an individualized estimate; 4) as there is no statistical modelling, the 264 
reliability of the results is based on the similarity between the population of the reference 265 
database and every-day patients rather than on complex statistical calculations; 5) the 266 
prediction tools based on models, such as logistic regression and neural networks provide a 267 
risk estimate in every case, also in patients whose combination of clinical characteristics are 268 
different from each patient¶s combination in the derivation cohort, giving the physician a 269 
false confidence. Conversely, AM would allow both the clinician and the patient to make a 270 
decision being aware that it might be based on uncertainty, rather than deciding on the false 271 
confidence provided by models. This is crucial in the perspective of a modern medicine 272 
increasingly based on personalized and shared decision making. 273 
AM has also some important limitations: 1) to be used in clinical practice the reference 274 
database should include a large number of patients; 2) the choice of predictors is crucial for 275 
the successful application of the method; 3) AM will promote personalized medicine, 276 
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providing the probability of events, rather than a clear indication of what to do (i.e. admit vs 277 
discharge). However, the need to interpret and apply the estimated probability to the context 278 
may be felt as a limitation due to lack of certainty; 4) a score is easy to remember and apply, 279 
while AM requires data collection and computer input ideally through a 280 
computer/smartphone app. Furthermore, the value of CDT as early and necessary work to 281 
determine the choice of predictors to be considered should not be under estimated as they 282 
help determine what attributes and factors should be collected and used for AM. 283 
Some limitations of the present study should be acknowledged. The database we used 284 
was collected for different purposes and, although we did our best to homogenize the data, 285 
we could not overcome some heterogeneity among the single studies¶ dataset. Also, we used 286 
as predictors the eight variables in common between the original datasets with no a priori 287 
decision on the number of predictors to be selected. However, this number strongly 288 
influences the sample size of the population to be included in the AM database. 289 
Nonetheless, it must be pointed out that syncope and this database were used only as a 290 
working example to show the possible applications of AM. 291 
 292 
Conclusions 293 
In conclusion, our study shows that the AM is a promising method to predict the risk of 294 
adverse events in clinical practice and could offer some advantages as compared with 295 
standard methods based on logistic regression. However, large datasets are required to 296 
obtain a precise and informative estimate. Future studies should explore the use of 297 
administrative databased or big data in conditions in which there is less clinical 298 
heterogeneity to use AM and to compare it with the traditional risk stratification tools. 299 
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